KAMADA LTD
KAMADA LTD (KMDA): 1 pipeline candidate · 1 upcoming catalyst · 2 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
N/A
0% dilution
Lead: Phase 3
1 candidate
1 upcoming, next in ~1809d
N/A
A transparent, data-derived signal for KAMADA LTDacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$431.3M
Cash
—
Quarterly Burn
$8.5M
Runway
—
Revenue
$44.7M
Cash Runway vs Catalysts
Upcoming catalyst timeline.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| alpha 1-antitrypsin | Phase 3 |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
39
Total value held
$511.9M
| Holder | Shares | Value |
|---|---|---|
| wells fargo & company/mn | 597,236 | $493.5M |
| renaissance technologies llc | 762,948 | $6.4M |
| ark investment management llc | 269,557 | $2.2M |
| two sigma investments, lp | 194,245 | $1.6M |
| envestnet asset management inc | 166,136 | $1.4M |
| marshall wace, llp | 149,993 | $1.3M |
| renaissance group llc | 125,901 | $1.1M |
| goldman sachs group inc | 72,955 | $608K |
| man group plc | 54,758 | $457K |
| millennium management llc | 46,934 | $391K |
Showing top 10 of 39 institutional holders of KAMADA LTD. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in KAMADA LTD's pipeline?
KAMADA LTD (KMDA) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is KAMADA LTD's lead drug candidate?
KAMADA LTD's most advanced tracked candidate is alpha 1-antitrypsin (Phase 3) for Alpha 1-Antitrypsin Deficiency.
What is KAMADA LTD's next catalyst?
KAMADA LTD's next tracked catalyst is a Phase3_Topline event — "Phase 3 Topline: Prospective Phase 3 Multi-center 2-Year Placebo Controlled Double Blind Study to Evaluate the Effica" — expected June 1, 2031.
What is KAMADA LTD's market capitalization?
KAMADA LTD's market capitalization is approximately $431.3M.
Who is the CEO of KAMADA LTD?
Mr. Amir London is the chief executive officer of KAMADA LTD (KMDA).
Get the full picture on KAMADA LTD
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.